ziv-aflibercept

A recombinant protein comprised of epitopes of the extracellular domains of human vascular endothelial growth factor receptors (VEGFR) fused to the… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BACKGROUND AND OBJECTIVE To investigate the retinal safety of intravitreal (IVT) ziv-aflibercept in rabbits. MATERIALS AND… (More)
Is this relevant?
2014
2014
PURPOSE To compare the safety profiles of antivascular endothelial growth factor (VEGF) drugs ranibizumab, bevacizumab… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2014
Highly Cited
2014
PURPOSE The antiangiogenic agent aflibercept (ziv-aflibercept in the United States) in combination with 5-fluorouracil… (More)
Is this relevant?
Highly Cited
2014
Highly Cited
2014
PURPOSE To evaluate the efficacy and safety of intravitreal aflibercept injections for treatment of macular edema secondary to… (More)
Is this relevant?
Highly Cited
2014
Highly Cited
2014
OBJECTIVE To assess the effectiveness of intravitreal aflibercept in patients with neovascular age-related macular degeneration… (More)
Is this relevant?
Highly Cited
2014
Highly Cited
2014
PURPOSE To evaluate the efficacy and safety of intravitreal aflibercept injection (IAI) for the treatment of macular edema… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
PURPOSE To evaluate intravitreal aflibercept injections (IAI; also called VEGF Trap-Eye) for patients with macular edema… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2013
Highly Cited
2013
PURPOSE To assess the efficacy of intravitreal aflibercept (2.0 mg) in patients with treatment-resistant neovascular age-related… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
PURPOSE Treatment for metastatic colorectal cancer (mCRC) commonly involves a fluoropyrimidine-based chemotherapy regimen such as… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
PURPOSE To compare the efficacy of aflibercept (ziv-aflibercept), a recombinant human fusion protein targeting the vascular… (More)
Is this relevant?